Skip to main content
Erschienen in: CardioVasc 1/2019

25.02.2019 | Blutdruckmessung | Fortbildung

Pro und Kontra

Absenkung der Zielblutdruckwerte im Alter

verfasst von: Prof. Dr. Timm H. Westhoff

Erschienen in: CardioVasc | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dass der Blutdruck auch bei Älteren und Hochbetagten eingestellt werden soll, steht außer Frage. Die Hypertonie unbehandelt zu lassen ist keine Option. Auf welche Werte die Einstellung erfolgen soll, ist allerdings einer Diskussion würdig und wird unterschiedlich gesehen. Lesen Sie eine ausführliche Erörterung des Themas durch zwei Experten.
Literatur
1.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219CrossRef Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219CrossRef
2.
Zurück zum Zitat James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20CrossRef James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20CrossRef
3.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324CrossRef Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324CrossRef
4.
Zurück zum Zitat Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041CrossRef Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041CrossRef
5.
Zurück zum Zitat Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98CrossRef Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98CrossRef
6.
Zurück zum Zitat Group SR, Wright JT, Jr., Williamson JD et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103–16CrossRef Group SR, Wright JT, Jr., Williamson JD et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103–16CrossRef
7.
Zurück zum Zitat Williamson JD, Supiano MA, Applegate WB et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged.75 Years: A Randomized Clinical Trial. JAMA. 2016;315(24):2673–82CrossRef Williamson JD, Supiano MA, Applegate WB et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged.75 Years: A Randomized Clinical Trial. JAMA. 2016;315(24):2673–82CrossRef
8.
Zurück zum Zitat Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014(3):CD000029. Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014(3):CD000029.
9.
Zurück zum Zitat Messerli FH, Mancia G, Conti CR et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144(12):884–93CrossRef Messerli FH, Mancia G, Conti CR et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144(12):884–93CrossRef
10.
Zurück zum Zitat McEvoy JW, Chen Y, Rawlings A et al. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. J Am Coll Cardiol. 2016;68(16):1713–22CrossRef McEvoy JW, Chen Y, Rawlings A et al. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. J Am Coll Cardiol. 2016;68(16):1713–22CrossRef
11.
Zurück zum Zitat Filipovsky J, Seidlerova J, Kratochvil Z et al. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood Press. 2016;25(4):228–34CrossRef Filipovsky J, Seidlerova J, Kratochvil Z et al. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood Press. 2016;25(4):228–34CrossRef
12.
Zurück zum Zitat Cheung AK, Rahman M, Reboussin DM et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017;28(9):2812–23CrossRef Cheung AK, Rahman M, Reboussin DM et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017;28(9):2812–23CrossRef
13.
Zurück zum Zitat Hajjar I, Rosenberger KJ, Kulshreshtha A et al. Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity. JAMA Neurol. 2017;74(10):1199–205CrossRef Hajjar I, Rosenberger KJ, Kulshreshtha A et al. Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity. JAMA Neurol. 2017;74(10):1199–205CrossRef
14.
Zurück zum Zitat Johnson KC, Whelton PK, Cushman WC et al. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018;71(5):848–57CrossRef Johnson KC, Whelton PK, Cushman WC et al. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018;71(5):848–57CrossRef
15.
Zurück zum Zitat Bauer F, Seibert FS, Rohn B, Bauer KAR, Rolshoven E, Babel N, et al. Attended Versus Unattended Blood Pressure Measurement in a Real Life Setting. Hypertension. 2018;71(2):243–9CrossRef Bauer F, Seibert FS, Rohn B, Bauer KAR, Rolshoven E, Babel N, et al. Attended Versus Unattended Blood Pressure Measurement in a Real Life Setting. Hypertension. 2018;71(2):243–9CrossRef
16.
Zurück zum Zitat Bohm M, Schumacher H, Teo KK et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085):2226–37CrossRef Bohm M, Schumacher H, Teo KK et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085):2226–37CrossRef
Metadaten
Titel
Pro und Kontra
Absenkung der Zielblutdruckwerte im Alter
verfasst von
Prof. Dr. Timm H. Westhoff
Publikationsdatum
25.02.2019
Verlag
Springer Medizin
Schlagwort
Blutdruckmessung
Erschienen in
CardioVasc / Ausgabe 1/2019
Print ISSN: 1617-4933
Elektronische ISSN: 1618-3851
DOI
https://doi.org/10.1007/s15027-019-1511-7

Weitere Artikel der Ausgabe 1/2019

CardioVasc 1/2019 Zur Ausgabe

Das könnte Sie auch interessieren

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.